A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis

Pharmacology, Toxicology and Pharmaceutical Science

• Amyotrophic Lateral Sclerosis 60%
• Clinical Trial 30%
• Deterioration 100%
• Disease Course 10%
• Disease Duration 10%
• Disease Exacerbation 50%
• Diseases 10%
• Indicator 30%
• Prognosis 20%
• Survival 10%
• Tenidap 10%

Neuroscience

• Amyotrophic Lateral Sclerosis 50%
• Amyotrophic Lateral Sclerosis Clinical Trial 10%

Biochemistry, Genetics and Molecular Biology

• Association 20%
• Data Base 10%
• Forced Vital Capacity 10%
• Survival 10%
• Time 10%